Stock Events

Stock Events

Accelerate Diagnostics

€0.000000

23

+€0.00+0% 00:00 Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1A8.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Guardant Health

Guardant Health, Inc. provides liquid biopsy tests that, like Accelerate Diagnostics, serve the diagnostics market with a focus on cancer, presenting a competitive edge in precision diagnostics.

Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. offers a range of products for the healthcare industry, including clinical diagnostics and life science research products that compete with Accelerate Diagnostics' offerings.

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing across several segments with Accelerate Diagnostics.

Danaher Corporation operates businesses in the environmental and applied solutions, life sciences, and diagnostics industries, competing with Accelerate Diagnostics in the diagnostics and research sectors.

QIAGEN N.V. offers sample to insight solutions that transform biological materials into valuable molecular insights, competing in the diagnostics and research market similar to Accelerate Diagnostics.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis, competing in the diagnostics and research market, particularly in genomics which is a growing area of diagnostics.

Agilent Technologies

Agilent Technologies, Inc. provides application-focused solutions in the life sciences, diagnostics, and applied chemical markets, directly competing with Accelerate Diagnostics in the diagnostics sector.

Becton Dickinson

Becton, Dickinson and Company offers a variety of medical devices and diagnostic products. While it has a broader focus, it competes with Accelerate Diagnostics in the diagnostics market, particularly in microbiology and infectious disease testing.

About

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Show more...

CEO

Mr. Jack Phillips

Employees

220

Country

United States

ISIN

US00430H1023

Listings

0 Comments

Share your thoughts

FAQ

What is Accelerate Diagnostics stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Accelerate Diagnostics stocks are traded under the ticker 1A8.STU.

How many employees does Accelerate Diagnostics have?▼

As of July 09, 2026, the company has 220 employees.

In which sector is Accelerate Diagnostics located?▼

Accelerate Diagnostics operates in the Health & Wellness sector.

When did Accelerate Diagnostics complete a stock split?▼

Accelerate Diagnostics has not had any recent stock splits.

Where is Accelerate Diagnostics headquartered?▼

Accelerate Diagnostics is headquartered in Tucson, United States.